Table 1.
Drug | Liposome Composition | Scaffold | Cross-Linking Method | Notes | Reference |
---|---|---|---|---|---|
Plasmid DNA encoding RUNX2 | DODAP, HSPC, Cholesterol, and DSPE-PEG or DSPE-PEG-Mal | Polycaprolactone nanofiber meshes | Thioether linkage of maleimide and thiol group | Osteogenic activities in human bone-marrow mesenchymal stem cells in vitro | [40] |
Dexamethasone | DODAP, HSPC, Cholesterol, and DSPE-PEG or DSPE-PEG-Mal | Polycaprolactone nanofiber meshes | Thioether linkage of maleimide and thiol group | Osteogenic activities in human bone-marrow mesenchymal stem cells in vitro | [44] |
Noggin siRNA | Stearylamine and cholesterol | Methacrylated glycol chitosan hydrogel | Encapsulation | Osteogenic and bone regeneration activities in vitro and in vivo | [41] |
Phenamil and Noggin siRNA | Stearylamine and cholesterol | Methacrylated glycol chitosan hydrogel | Encapsulation | Osteogenic and bone regeneration activities in vitro and in vivo | [42] |
20(s)-hydroxycholesterol and Plasmid DNA encoding sonic hedgehog | Palmitic acid and 20(s)-hydroxycholesterol | Porous hydroxyapatite-coated PLGA scaffold | Electrostatic interaction of alendronate and apatite | Osteogenic and bone regeneration activities in vitro and in vivo | [22] |
Kartogenin | Lecithin and cholesterol | Gelatin methacryloyl hydrogel | Encapsulation via the physical network hindrance and non-covalent interaction | Extended joint retention, in vitro chondrogenic activities, and therapeutic effects in osteoarthritis model in vivo | [37] |
Dexamethasone | (N-{6-amino-1-[N-(9Z) -octadec9-enylamino] -1-oxohexan-(2S) -2- yl} –N’- {2- [N, N-bis(2-aminoethyl) amino] ethyl} -2-hexadecylpropandiamide) (OO4) and DOPE |
Glass coverslips, gold sensors, and silicon substrates |
Layer-by-Layer coating with polyethyleneimine, collagen type I, chondroitin sulfate, and liposome | Enhanced adhesion and osteogenic differentiation of C2C12 myoblasts in vitro | [43] |
Salvianic acid A | Lecithin, cholesterol, and cholesterol-pyrophosphate | Collagen sponge | Absorption | Improved bone healing via the regulation of HDAC3-mediated endochondral ossification in rabbit segmental defect model | [23] |
Deferoxamine and BMP-2 | Phosphatidylcholin and Chol |
Gelatin methacryloyl hydrogel | Hydrogen bond and hydrogel network micro-cross-linking | Enhanced mechanical property by liposome encapsulation, controlled phase release of various type of drugs, osteogenesis, angiogenesis, mature lamella bone formation in vivo | [38] |
Deferoxamine | Lecithin and cholesterol | Gelatin methacryloyl hydrogel and 3D printed bioceramic scaffold | Encapsulation | Designed biomimetic ‘lotus’ biological structure, increased the expression of vascularization, and pro-osteogenic effects in vitro/in vivo | [39] |
Curcumin | 1,2-dimyristoylsn-glycero-3-phosphocholine (DMPC) and 1,2-dimyristoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (sodium salt) (DMPG) | 3D printed calcium phosphate scaffolds | Absorption and ionic interaction | Cytotoxic against in vitro osteosarcoma (bone cancer) cells and promoted osteoblast (healthy bone cell) cell growth |
[34] |
20(s)-hydroxycholesterol | Stearylamine and 20(s)-hydroxycholesterol | Methacrylated glycol chitosan hydrogel | Encapsulation | Designed non-phospholipid liposome, named sterosome, which has intrinsic osteoinductivity, and enhanced osteogenic activities in vitro and bone formation in vivo via hedgehog signaling | [27] |
20(s)-hydroxycholesterol and purmorphamine | Stearylamine and 20(s)-hydroxycholesterol | Porous PLGA scaffold | Polydopamine-mediated layer-by-layer coating (Schiff base formation and Michael-type addition) | Osteogenic activities in vitro and bone formation in vivo via hedgehog signaling | [29] |
20(s)-hydroxycholesterol and smoothened agonist (SAG) | Stearylamine and 20(s)-hydroxycholesterol | Porous hydroxyapatite-coated PLGA scaffold | Polydopamine-mediated layer-by-layer coating (Schiff base formation and Michael-type addition) | Osteogenic activities in vitro and bone formation in vivo via hedgehog signaling | [30] |
Aspirin and bone forming peptide-1 | DSPE-PEG-NH2, 1,2- dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), and cholesterol | 3D printed polycaprolactone scaffold | Polydopamine-mediated coating | Osteogenic activities in vitro and bone formation in vivo via PI3K/AKT signaling | [36] |
Aspirin | DSPE-PEG-NH2, DPPC, and cholesterol | 3D printed polycaprolactone scaffold | Polydopamine-mediated coating | Osteogenic activities in vitro and ectopic bone formation in vivo | [35] |
BMP-2 peptide | HSPC or DPPC, Cholesterol, and mPEG-DSPE-maleimide | Electrospun poly L-lactic acid nanofibers | Thioether linkage of maleimide and thiol group | Sustained release of BMP-2 peptide up to 21 days, enhanced in vitro osteogenic activities, and initiated ectopic bone formation | [33] |
107–111 pentapeptide of the parathyroid hormone-related protein (PTHrP 107-111) | MSPC, DSPE-PEG-maleimide, and DPPC | Collagen-hydroxyapatite scaffolds | Thioether linkage of maleimide and thiol group | Triggered release of PTHrP 107-111 by thermal stimulation and enhanced pro-osteogenic activities in vitro | [18] |
N′-Dodecanoylisonicotinohydrazide | Phospholipid | PLGA-PEG-PLGA hydrogel | Encapsulation | Developed a liposome-in-hydrogel and sustained drug release | [19] |
Carboxyfluorescein, doxorubicin, and lysozyme; not for bone tissue engineering | DSPC, cholesterol, and DSPE-PEG or DSPE-PEG-thiol bisphosphonate | Collagen-hydroxyapatite scaffolds | Electrostatic interaction of bisphosphonate and apatite | Increased affinity to the scaffold and sustained drug release | [21] |
BMP-2 | Lecithin, cholesterol, and octadecylamine | PEG and Ag ion hydrogel | Encapsulation | Promoted osteogenic differentiation in vitro and local bone remodeling of osteoporotic fracture in vivo because of increased localization efficacy at injected site | [20] |
CKIP-1 siRNA | DOTAP, DOPE, cholesterol, DSPE-mPEG2000, and DSPE-PEG2000-maleimide |
Bovine bone scaffold | Electrostatic interaction | Osteogenic activities in vitro and bone repair in vivo via CKIP-1 knock down | [25] |